Real-world safety of Symdeko: insights from the food and drug administration adverse event reporting system
BackgroundSymdeko, a cystic fibrosis transmembrane conductance regulator (CFTR), is widely utilized for treating cystic fibrosis (CF). Although its safety has been validated in numerous clinical trials, the real-world safety profile still needs further investagation.MethodsThis study analyzed advers...
| Published in: | Frontiers in Medicine |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-10-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1681985/full |